Ginsenoside Rg3 Sensitizes Colorectal Cancer to Radiotherapy through Downregulation of Proliferative and Angiogenic Biomarkers

BACKGROUND: Radiation therapy is an important mode of colorectal cancer treatment. However, most people die of local recurrence after tumors become resistant to radiotherapy, and little progress has been made in treating radiotherapy-resistant colorectal cancer. Hence, novel agents that are nontoxic...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Taiguo, Duo, Lina, Duan, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5878898/
https://www.ncbi.nlm.nih.gov/pubmed/29743919
http://dx.doi.org/10.1155/2018/1580427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5878898/
https://www.ncbi.nlm.nih.gov/pubmed/29743919
http://dx.doi.org/10.1155/2018/1580427

Ejemplares similares